Turing Pharmaceuticals CEO Martin Shkreli on Friday defended, without apology, his decision to up the price of the drug Daraprim from $3.50 a pill to $750, during an online interview Friday at ...
“Pharma Bro” Martin Shkreli has published a detailed bull case for photonic computing Thursday , sayinghe is now actively working at Q/C Technologies Inc. QCLS, the micro-cap firm he first invested in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results